drugset / Trial / NCT00003016

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

NCT00003016

Phase 3 Unknown 20000 enrolled University of Oxford
RandomizedTreatment

Summary

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by reducing the production of estrogen. It is not yet known if prolonged tamoxifen is more effective than shorter tamoxifen therapy following curative treatment for breast cancer. PURPOSE: This randomized phase III trial is studying giving tamoxifen over a prolonged period of time to see how well it works compared to giving tamoxifen over a shorter period of time in treating patients who have had a breast tumor removed.

Timeline

Start
1995-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamoxifen Small molecule

Indications